User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

2581

Interactions with Platform & by Email *

INTERACTIONS

465

Unique # Participated *

PARTICIPANTS

77

Responses Validated *

VALIDATIONS

22

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
Quantitative Techniques & Analytics.....I-2
  
   Product Definition and Scope of Study.....I-3
Smoking Cessation Aids.....I-3
Definitions.....I-3
A. Nicotine Gum .....I-3
  
   B. Nicotine Patch.....I-4
C. Nicotine Lozenges And Tablets.....I-4
D. Others.....I-4
Nicotine Inhaler.....I-4
Nicotine Nasal Spray.....I-4
  
   Leading Players.....II-1
Tobacco Products Industry: An Introduction.....II-1
1$100
   Regulations/Taxes.....II-2
Black Market.....II-2
1$100
   Cigarette: The Tobacco King.....II-3
Cigars: All Rolled Up.....II-3
Glut of Products Restrain Growth.....II-3
Major Cigar Tobacco Producing Regions.....II-3
1$100
   China Dominates the Cigarettes Sector.....II-4
Competitive Scenario.....II-4
Table 1: World Cigarettes Market for 2004 & 2005: Market Shares Based on Volume Sales of Leading Manufacturers for Philip Morris, British American Tobacco, Japan Tobacco, Imperial Tobacco, Gallaher, Reynolds American and Others (includes corresponding Graph/Chart).....II-4
1$300
   Table 2: World Recent Past, Current & Future Analysis for Cigarettes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Billion Units for Years 2000 2006 and 2010 (includes corresponding Graph/Chart).....II-5

Table 3: World Recent Past, Current & Future Analysis for Cigars by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 2006 and 2010 (includes corresponding Graph/Chart).....II-5
1$300
   Table 4: World Recent Past, Current & Future Analysis for Cigarettes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Billion for Years 2000 2006 and 2010 (includes corresponding Graph/Chart).....II-6

Table 5: World Recent Past, Current & Future Analysis for Cigars by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000, 2006 and 2010 (includes corresponding Graph/Chart).....II-6
1$300
   Why to Quit Smoking.....II-7
Secondhand Smoke.....II-7
Why Smoking is Hard to Quit.....II-7
1$100
   Methods of Smoking Cessations.....II-8
Cold Turkey.....II-8
1$100
   Drug Therapies.....II-9
Other Interventions.....II-9
Benefits of Quitting Smoking.....II-9
2$200
   World Smoking Statistics.....II-11
1$100
   Smoking Cessation Aids Defined.....II-12
Nicotine Gum.....II-12
Factors to Consider.....II-12
1$100
   Effectiveness of Nicotine Gum.....II-13
Nicotine Patch.....II-13
1$100
   Factors to Consider.....II-14
Nicotine Lozenges & Tablets.....II-14
1$100
   Factors to Consider.....II-15
Other Smoking Cessation Aids.....II-15
Nicotine Inhaler.....II-15
Factors to Consider.....II-15
1$100
   Nicotine Nasal Spray.....II-16
Factors to Consider.....II-16
Non-Nicotine Based Medications.....II-16
1$100
   Inundate Anti-Smoking Vaccines Kindles Underdeveloped Prescription Market.....II-17
Strict Regulations Deter Smoking Cessation Aids.....II-17
1$100
   Growing Anti Smoking Campaigns.....II-18
Health Concerns.....II-18
Corporations Initiate for Smoke Free Work Environment.....II-18
1$100
   Television Advertisements – Most Effective Media for Smoking Cessation.....II-19
Public Awareness through Internet.....II-19
Rising Prices of Tobacco – A Key Strategy for Quitting Smoking.....II-19
1$100
   Acomplia to Enter Smoking Cessation Market.....II-20
Fertin Phiarma and Perrigo to Launch Nicotine Gum in the US Market.....II-20
Nic๘drops Unveils New Lozenge for Smoking Cessation.....II-20
Pharmacia and Takeda to Launch Smoking Cessation Aid in Japan.....II-20
Glaxo Unveils First Anti-Smoking Medicine in India.....II-20
1$100
   Pfizer Japan to Roll Out Champix Anti-Smoking Drug.....II-21
Inverness Medical Innovations Pockets Bio-Stat Healthcare Group.....II-21
Novartis New Smoking Cessation Aids Gets FDA’s Approval.....II-21
Johnson & Johnson Concludes Take Over of Pfizer Consumer Healthcare.....II-21
1$100
   Pfizer Receives FDA Approval for Smoking Cessation Medicine Chantix™.....II-22
Perrigo Obtains FDA Approval to Sell Coated Nicotine Gum.....II-22
Pfizer Receives Chinese Approval for Clinical Trials on Smoking Cessation Aid.....II-22
Pfizer Receives EC Approval for New Varenicline.....II-22
Formation of Sanofi-Aventis.....II-22
1$100
   AXIA Health Management Acquires Smoking Cessation Website.....II-23
Nicodrops Receives EC Approval for Smoking Cessation Aid.....II-23
Nabi Unveils Successful Phase II Results for Smoking Cessation Vaccine.....II-23
FDA Grants Approval for High Strength Bupropion.....II-23
1$100
   Watson Pharmaceuticals Receives Rights to Market Zybanฎ.....II-24
Pfizer Merges with Pharmacia.....II-24
FDA Approves Anti-Smoking Medication for OTC Sales.....II-24
GSK and Taisho to Develop Anti-Smoking Medication.....II-24
Johnson & Johnson Acquires Alza.....II-24
1$100
   GlaxoSmithKline Plc (UK).....II-25
Johnson & Johnson Inc. (USA).....II-25
Novartis Consumer Healthcare Inc. (USA).....II-25
1$100
   Perrigo Company (USA).....II-26
Pfizer Inc. (USA).....II-26
1$100
   Table 6: World Recent Past, Current & Future Analysis for Smoking Cessation Aids by Geographic Region – US, Canada, Europe and Rest of World Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart).....II-271$300
   Table 7: World Long Term Projections for Smoking Cessation Aids by Geographic Region – US, Canada, Europe and Rest of World Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart).....II-281$300
   Table 8: World 10-Year Perspective for Smoking Cessation Aids by Geographic Region – Percentage Break down of Dollar Sales for US, Canada, Europe and Rest of the World for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....II-291$300
   A. Market Analysis.....III-1
Outlook.....III-1
Cigarette Smoking Decline Stagnates in the US.....III-1
Smoking Women are at High Risk.....III-1
Tobacco Companies Spend Big on Advertising.....III-1
NRT - A Peer into the Past.....III-1
1$75
   Popular NRT Brands in the US Market.....III-2
Key Statistics:.....III-2
Table 9: Top 4 Nicotine Chewing Gum Brands in the US: Breakdown of Dollar Sales Through Supermarkets, Drug Stores & Discount Stores for the Year Ended November 2007 (In US$ 000).....III-2
1$150
   Table 10: US Market for Smoking Cessation Products: Percentage Share Breakdown of Value and Volume Sales by Product Category – Gum, Patch, Tablets, and Others (incl. Mouth Spray, Filters) for the Year Ended November 2007 (includes corresponding Graph/Chart).....III-3

Table 11: Leading NRT Brands in the US Market by Product Type in 2005: Sales in US$ Millions for Nicorette, Nicoderm CQ, Commit and Other Brands & Private Labels (includes corresponding Graph/Chart).....III-3
1$150
   Product Launches/Developments.....III-4
Strategic Corporate Developments.....III-4
2$150
   Key Players.....III-63$225
   B. Market Analytics.....III-9
Table 12: US Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches and Lozenges & Tablets Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart).....III-9

Table 13: US Long Term Projections for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches and Lozenges & Tablets Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart).....III-9
1$150
   Table 14: US 10-Year Perspective for Smoking Cessation Aids by Product Segment – Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches and Lozenges & Tablets for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-10
1$150
   A. Market Analysis.....III-11
Outlook.....III-11
B. Market Analytics.....III-11
Table 15: Canadian Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches and Lozenges & Tablets Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart).....III-11
1$150
   Table 16: Canadian Long Term Projections for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches and Lozenges & Tablets Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart).....III-12

Table 17: Canadian 10-Year Perspective for Smoking Cessation aids by Product Segment – Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches and Lozenges & Tablets for the Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-12
1$150
   A. Market Analysis.....III-13
Outlook.....III-13
Strategic Corporate Developments.....III-13
1$75
   Key Players.....III-142$150
   B. Market Analytics.....III-16
Table 18: European Recent Past, Current & Future Analysis for Smoking Cessation Aids by Geographic Region – France, Germany, UK, Italy, Spain & Rest of Europe Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart).....III-16
1$150
   Table 19: European Long Term Projections for Smoking Cessation Aids by Geographic Region – France, Germany, UK, Italy, Spain & Rest of Europe Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart).....III-171$150
   Table 20: European Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart).....III-18

Table 21: European Long Term Projections for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart).....III-18
1$150
   Table 22: European 10-Year Perspective for Smoking Cessation Aids by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, Spain, Russia and Rest of Europe for the Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-19

Table 23: European 10-Year Perspective for Smoking Cessation Aids by Product Segment – Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others for the Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-19
1$150
   A. Market Analysis.....III-20
Outlook.....III-20
B. Market Analytics.....III-20
Table 24: French Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales Figures in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart).....III-20
1$150
   Table 25: French Long Term Projections for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart).....III-21

Table 26: French 10-Year Perspective for Smoking Cessation Aids by Product Segment – Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Others for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-21
1$150
   A. Market Analysis.....III-22
Outlook.....III-22
B. Market Analytics.....III-22
Table 27: German Recent Past, Current & Future Analysis for Smoking Cessation aids by Product Segment – Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-22
1$150
   Table 28: German Long Term Projections for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart).....III-23

Table 29: German 10-Year Perspective for Smoking Cessation aids by Product Segment – Percentage Breakdown of Value Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Other Markets for 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-23
1$150
   A. Market Analysis.....III-24
Outlook.....III-24
Table 30: Leading OTC-NRT Brands by Company in the UK in 2005: Percentage Breakdown of Value Sales for Nicorette, Niquitin CQ, Nicotinell and Others (includes corresponding Graph/Chart).....III-24

Table 31: NRT Advertisement Expenditure by Leading Companies in the UK in 2005: Percentage Breakdown for Pfizer, GlaxoSmithKline, Novartis and Others (includes corresponding Graph/Chart).....III-24
1$150
   B. Market Analytics.....III-25
Table 32: UK Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart).....III-25
1$150
   Table 33: UK Long Term Projections for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart).....III-26

Table 34: UK 10-Year Perspective for Smoking Cessation Aids by Product Segment – Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others for the Years 2003,2008 and 2012 (includes corresponding Graph/Chart).....III-26
1$150
   A. Market Analysis.....III-27
Outlook.....III-27
B. Market Analytics.....III-27
Table 35: Italian Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches, Lozenges and Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart).....III-27
1$150
   Table 36: Italian Long Term Projections for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart).....III-28

Table 37: Italian 10-Year Perspective for Smoking Cessation Aids by Product Segment – Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-28
1$150
   A. Market Analysis.....III-29
Outlook.....III-29
B. Market Analytics.....III-29
Table 38: Spanish Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart).....III-29
1$150
   Table 39: Spanish Long Term Projections for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart).....III-30

Table 40: Spanish 10-Year Perspective for Smoking Cessation Aids by Product Segment – Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-30
1$150
   A. Market Analysis.....III-31
Outlook.....III-31
B. Market Analytics.....III-31
Table 41: Rest of Europe Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart).....III-31
1$150
   Table 42: Rest of Europe Long Term Projections for Smoking Cessation Aids by Product Segment – Nicotine Gum, Nicotine Patches, Lozenges & Tablets, and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart).....III-32

Table 43: Rest of Europe 10-Year Perspective for Smoking Cessation Aids by Product Segment – Percentage Breakdown of Dollar Sales for Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-32
1$150
   A. Market Analysis.....III-33
Outlook.....III-33
Smoking Statistics in China.....III-33
Barriers to Promote Smoking Cessation in the Developing World.....III-33
Economic Factors.....III-33
Inadequate Policies to Support Cessation.....III-33
1$75
   Low Perception of Risk among Public and Policy Makers.....III-34
Poor Healthcare Systems and Infrastructure.....III-34
Lack of Technology.....III-34
Strategic Corporate Developments.....III-34
1$75
   Product Launches.....III-351$75
   B. Market Analytics.....III-36
Table 44: Rest of World Recent Past, Current & Future Analysis for Smoking Cessation Aids – Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart).....III-36

Table 45: Rest of World Long Term Projections for Smoking Cessation Aids – Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart).....III-36
1$150